Newbridge Financial Services Group, Inc. Emergent Bio Solutions Inc. Transaction History

Newbridge Financial Services Group, Inc.

  • $372 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023
SELL
$3.17 - $7.91 $8,083 - $20,170
-2,550 Reduced 83.61%
500 $1,000
Q2 2023

Jul 21, 2023
SELL
$7.35 - $13.21 $26,460 - $47,556
-3,600 Reduced 54.14%
3,050 $22,000
Q1 2023

Apr 18, 2023
BUY
$7.79 - $16.29 $51,803 - $108,328
6,650 New
6,650 $68,000

Others Institutions Holding EBS

# of Institutions
158
Shares Held
33.8M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $561M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email